HL
The startup develops cell-based therapies utilizing human-derived cells from umbilical cord tissue to repair tissue damage and treat intractable diseases. This approach provides healthcare professionals with a method to enhance patient recovery and improve outcomes for conditions that are difficult to manage with conventional treatments.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops cell-based therapies utilizing human-derived cells from umbilical cord tissue to repair tissue damage and treat intractable diseases. This approach provides healthcare professionals with a method to enhance patient recovery and improve outcomes for conditions that are difficult to manage with conventional treatments.